January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

July 24, 2014

GlaxoSmithKline announced that the Food and Drug Administration has approved Flonase Allergy Relief as an over-the-counter treatment.

July 21, 2014

AbbVie has finalized a deal for Dublin-based specialty pharmaceuticals company Shire for $54.7 billion.

July 16, 2014

Sun Life Assurance Company of Canada entered into a strategic business relationship with McKesson Canada to launch the Sun Life Preferred Pharmacy Network.

July 16, 2014

RetireSafe, a grassroots organization advocating on behalf of America’s seniors on Tuesday released a survey finding that seniors overwhelmingly support strong patient safeguards for biosimilar medications. 

July 15, 2014

Giant Eagle last week added prescription blood-pressure medications lisinopril and lisinopril HCTZ to the list of several antibiotics that the chain provides for free to its patients, according to a report in the Columbus Dispatch

July 14, 2014

In an effort to battle medication non-adherence, regional player Kinney Drugs has unveiled its new EZSync program to synchronize pickup dates and prescription refills.

July 14, 2014

Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.

July 11, 2014

Anacor Pharmaceuticals announced that the Food and Drug Administration has approved the company's new drug application for Kerydin (tavaborole) topical solution, 5% — an antifungal approved for the topical treatment of onychomycosis of the toenails.

June 25, 2014

Worldwide prescription drug sales are expected to exceed the trillion dollar mark by 2020, according to Evaluate's "World Preview 2014, Outlook to 2020" report released Wednesday.

June 23, 2014

America’s biopharmaceutical research companies are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population, according to a new report released by the Pharmaceutical Research and Manufacturers of America last week.

June 19, 2014

Meijer pharmacies marked a milestone in June when one of the retailer's pharmacists dispensed the 20 millionth free customer prescription through its free prescription program.

June 9, 2014

As healthcare decision-makers grapple with how to ensure access to specialty medications, the University of Michigan Center for Value-Based Insurance Design and the National Pharmaceutical Council on Monday released a new report, "Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design," which explores how value-based insurance design could be utilized to address specialty medication access concerns.

May 29, 2014

There may be a connection between taking vasodilators and developing early-stage, age-related macular degeneration, the leading cause of vision loss and blindness among Americans who are ages 65 and older, according to a study published online Wednesday in Ophthalmology, the journal of the American Academy of Ophthalmology.

May 27, 2014

Pfizer on Tuesday announced the introduction in the United States of over-the-counter Nexium 24HR, making the "Purple Pill" available for the treatment of frequent heartburn in adults.

May 15, 2014

The stampede of big-selling branded medicines that hurtled off the patent cliff in 2011 and 2012 has slowed to a relative trickle.

May 14, 2014

About half of all Americans reported taking one or more prescription drugs in the past 30 days during 2007-2010, and 1-in-10 took five or more, according to "Health, United States, 2013," the government’s annual, comprehensive report on the nation’s health that was released Wednesday.

May 6, 2014

AstraZeneca on Tuesday announced the Food and Drug Administration approved Epanova (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500 mg/dL).

April 28, 2014

U.S. pharmaceutical firm Pfizer this morning confirmed discussions with AstraZeneca regarding a possible merger. If the transaction goes through, it's expected that the two companies will combine under a new U.K-incorporated holding company.

April 25, 2014

The Generic Pharmaceutical Association has announced its support of the U.S. Drug Enforcement Administration’s eighth annual National Prescription Drug Take-Back Day, taking place April 26 at local take-back sites across America.

March 31, 2014

The Food and Drug Administration on Friday approved over-the-counter Nexium 24HR (esomeprazole 20mg), Pfizer announced.

March 27, 2014

Indiana Governor Mike Pence earlier this week signed legislation designed to create a pathway for the substitution of interchangeable biologic medicines, according to published reports.

March 20, 2014

AstraZeneca on Wednesday launched Nexium Direct, a program that provides eligible patients the option of having brand-name Nexium delivered directly to their home.

March 13, 2014

More Americans are more often seeking their ounce of prevention. According to Bain & Co.’s recent Healthy Living Survey, 75% of consumers are in pursuit of a healthier lifestyle. Take that predominant mindset, coupled with the outcomes-driven preventive focus associated with the Affordable Care Act, and you have a formula for OTC success at retail pharmacy.